These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32565052)

  • 1. Is the paradigm of community pharmacy practice expected to shift due to COVID-19?
    Nadeem MF; Samanta S; Mustafa F
    Res Social Adm Pharm; 2021 Jan; 17(1):2046-2048. PubMed ID: 32565052
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication therapy management: reflecting on the profession's progress.
    Cerulli J
    J Am Pharm Assoc (2003); 2008; 48(6):712, 714. PubMed ID: 19019798
    [No Abstract]   [Full Text] [Related]  

  • 3. Irrational pharmacy practice and inadequate health care services in Bangladesh: a lesson learned from COVID-19 pandemic.
    Jakaria M; Azam S; Siddiqui SA; Hoq MI; Islam MS
    J Basic Clin Physiol Pharmacol; 2021 Apr; 32(3):129-130. PubMed ID: 33915611
    [No Abstract]   [Full Text] [Related]  

  • 4. Chinese pharmacists' rapid response to the COVID-19 outbreak.
    Tan SL; Zhang BK; Xu P
    Am J Health Syst Pharm; 2020 Jul; 77(14):1096-1097. PubMed ID: 32399549
    [No Abstract]   [Full Text] [Related]  

  • 5. Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic.
    Hussain R; Dawoud DM; Babar ZU
    Res Social Adm Pharm; 2021 Jan; 17(1):1920-1924. PubMed ID: 32792322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2010 Sep; 6(3):163-73. PubMed ID: 20813330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success.
    Taddei-Allen P
    J Manag Care Spec Pharm; 2020 Jun; 26(6):708-710. PubMed ID: 32463767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
    Carico RR; Sheppard J; Thomas CB
    Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed model for hospital and community pharmacy services during COVID-19 pandemic in Nigeria.
    David KB; Adebisi YA
    Int J Pharm Pract; 2020 Oct; 28(5):544-545. PubMed ID: 32621648
    [No Abstract]   [Full Text] [Related]  

  • 13. Disruptive innovation in community pharmacy - Impact of automation on the pharmacist workforce.
    Spinks J; Jackson J; Kirkpatrick CM; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(2):394-397. PubMed ID: 27283243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs.
    Hedima EW; Adeyemi MS; Ikunaiye NY
    Res Social Adm Pharm; 2021 Jan; 17(1):1964-1966. PubMed ID: 32317154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restructuring the role of the community pharmacists.
    White EV; Latif DA
    J Am Pharm Assoc (2003); 2006; 46(5):532, 535. PubMed ID: 17036638
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
    Hermansyah A; Sainsbury E; Krass I
    Res Social Adm Pharm; 2017; 13(4):727-737. PubMed ID: 27530306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development.
    Matheson C; Thiruvothiyur M; Robertson H; Bond C
    Int J Drug Policy; 2016 Jan; 27():105-12. PubMed ID: 26723885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a vision and strategic action plan for future community-based residency training.
    Skelton JB; Owen JA
    J Am Pharm Assoc (2003); 2016; 56(5):584-589.e1. PubMed ID: 27594109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal.
    Amariles P; Ledezma-Morales M; Salazar-Ospina A; Hincapié-García JA
    Res Social Adm Pharm; 2021 Jan; 17(1):1988-1989. PubMed ID: 32224133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy practice around the world.
    Lutz EM; Rovers J; Mattingly J; Reed BN
    J Am Pharm Assoc (2003); 2009; 49(1):4-11. PubMed ID: 19196590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.